ORTEXORTEX News
Tracking XEL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
XE
Earnings PreviewXEL

XEL Options Flash a Rare Warning Ahead of Q1 Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 19 May 2026, 04:00

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of Xcel Energy Inc. (XEL) share price and short interest (% of free float), three months to May 15, 2026
ORTEX data as of 19 May 2026, 04:00

Xcel Energy heads into its May 20 earnings release with options traders more defensively positioned than at any point in the past year.

The put/call ratio has surged to 1.37 — more than three and a half standard deviations above its 20-day average of 0.40. That is the highest reading recorded in the past 52 weeks, against a low of 0.13. The move is striking in its speed: the PCR sat below 0.30 as recently as mid-May, meaning the defensive tilt arrived almost entirely in the final session before the print. The stock itself has given back ground, falling around 2.6% on Friday and 1.9% on the week to close at $77.92.

Short interest tells a calmer story. Bears hold roughly 4.8% of the free float — up about 12% over the past month, but still well within normal territory for a regulated utility. Borrow conditions offer no squeeze pressure: availability runs at 1,454%, meaning lenders hold nearly fifteen times as many shares as are currently borrowed. Cost to borrow is a negligible 0.56%, even after ticking up around 7% on the week. The short score of 44 places XEL in the lower quartile of short-squeeze risk. This is not a setup built around short sellers; they are a sideshow.

The bull case rests on a sector with unusually strong forward earnings momentum. The 12-month forward EPS growth estimate ranks in the 89th percentile of the universe, and XEL carries a near-perfect analyst recommendation score — the 98th percentile on analyst consensus divergence signals that the Street is overwhelmingly constructive. The mean price target from analysts currently active on the stock is $91.83, implying roughly 18% upside from current levels. JP Morgan trimmed its target to $91 from $94 last week while holding its Overweight rating, and Truist Securities cut to $92 from $95 while maintaining Buy — a pattern of modest calibration rather than conviction loss. Barclays also trimmed to $87 earlier in May. Bears, to the extent they have a case, point to the stock's 8% year-to-date gain outpacing utility peers: LNT, OGE, EVRG, DUK and AEP all fell between 1% and 4% on the week alone, making XEL's relative resilience a potential mean-reversion target.

The prior quarter's print delivered a 4.8% one-day gain, so the earnings reaction has historically rewarded holding through the release. Tomorrow's numbers will test whether that analyst consensus — uniformly positive, gently trimmed — can survive contact with the actual cost and margin figures at a moment when the options market is hedging harder than it has all year.

Against its peers

Shares moved -1.9% over the past week against a median of -1.9% for its closest peers.

Stocks in this article

See the live data behind this article on ORTEX.

Open XEL on ORTEX →

How this article was generated

Generated
19 May 2026, 04:08
Data as of
19 May 2026, 04:00
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.